ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Galephar Pharmaceutical Research INC

Official 2024 U.S. DOL Form 5500 summary for Galephar Pharmaceutical Research INC (Galephar Pharmaceutical Retirement Plan · EIN 66-0565645 · PN 001): $464,010 net assets, 107 active participants, and $265.46 per $10,000 (265.46 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorGalephar Pharmaceutical Research INC
Filing IdentifierGalephar Pharmaceutical Retirement Plan · EIN 66-0565645 · PN 001
Plan Category & State401(k) Defined Contribution (PR)
Asset-Size Peer Cohort<$1M
Plan Net Assets (2024)$464,010
Active Participants107
Direct Admin Fee Rate$265.46 per $10,000 (265.46 bps)
Cohort Peer MedianN/A
Primary Recordkeeper / ProviderEmpower Retirement
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($21,602, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI